Clinical Trial News and Research

RSS

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

For the first time ever, studies in Mexico and Africa, published today in the New England Journal of Medicine, demonstrate a reduction in diarrheal disease deaths following rotavirus vaccine introduction in Mexico and vaccine efficacy among impoverished populations in Malawi and South Africa.

28 Jan 2010

Orthopaedic researchers explore novel treatments for wounded soldiers

For each action, there is an equal and opposite reaction. So after the surge in U.S. troops heading to Afghanistan, there will be an influx of injured veterans returning back home. But the U.S. Department of Defense has recruited its own "soldiers" in the battle against war casualties: a consortium of researchers who are improving care to wounded soldiers as well as the general public.

28 Jan 2010

PHT announces enhanced StudyWorks portal for clinical trial management

PHT Corporation continues to drive the ePRO (electronic patient reported outcome) industry forward. The company today announced an enhanced StudyWorks™ portal that offers study sponsors an unprecedented level of management and logistical control over their clinical trials. PHT is the leading provider of ePRO solutions used in more than 400 clinical trials worldwide.

28 Jan 2010

New report illustrates why cardiovascular disease is under-recognized and under-treated in women

Today, the Society for Cardiovascular Angiography and Interventions (SCAI) launched "WINHeart -- Score a WIN for Women," an initiative that raises awareness surrounding gender-based disparities in the diagnosis, treatment and survival of women with cardiovascular disease (CVD).

28 Jan 2010

Special issue explores how evolution can help doctors understand and treat diseases

What does evolution - a field that often deals with changes over many generations - have to do with preventing and treating disease in our lifetime?

28 Jan 2010

GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patients

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.

28 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

Seroquel XR's FDA approval does not change Decision Resources' earlier antipsychotics market forecast

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.

28 Jan 2010

Santica Research Labs launches CelluScience Anti-Cellulite Beaute Intensive dietary supplement

More than 85% of women in the U.S. have cellulite. Now, there is a revolutionary new anti-cellulite dietary supplement clinically proven to help target the thighs, hips and gluteal area.

28 Jan 2010

Scientists uncover a key cellular mechanism that alters brain cell function in Huntington's disease

Scientists at the Brain Research Centre and Centre for Molecular Medicine and Therapeutics have uncovered a key cellular mechanism that alters brain cell function in Huntington's disease, and identified a possible treatment for the disease.

28 Jan 2010

PRA International enters into partnership agreement with Oncopartners and IBPC

PRA International, a leading Clinical Research Organization, announces it has entered into a partnership agreement with Oncopartners, a leading Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network comprised of Brazil's largest public oncology hospitals which collectively treat an estimated 140,000 new incidences of cancer annually.

28 Jan 2010

Abbott declares quarterly dividend of 40 cents per share

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2009.

27 Jan 2010

Positive results from Supernus Pharmaceuticals' SPN 810 Phase IIa trial for ADHD

Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.

27 Jan 2010

EU Clinical Trials Directive: ECCO supports proposals by its member organisations

In response to a European Commission consultation on the EU Clinical Trials Directive, ECCO - the European CanCer Organisation - has supported proposals by its member organisations for adapting the Directive's requirements to reflect practical necessities in cancer research and treatment.

27 Jan 2010

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

According to data appearing today in JAMA, patients with a common heart rhythm disorder, called Atrial Fibrillation, who were treated with catheter ablation using the NAVISTAR® THERMOCOOL® Catheter, demonstrated significantly better outcomes at one year compared to those receiving drug therapy. In addition, the patients treated with catheter ablation reported markedly fewer symptoms and substantially improved quality of life.

27 Jan 2010

Souvenaid slows worsening of memory difficulties in persons with mild to moderate Alzheimer's

Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's.

27 Jan 2010

Trial results show primary care doctors are capable of helping obese patients to lose weight

Despite a general belief among physicians that extreme obesity is too difficult to treat, except with bariatric surgery, researchers at the Pennington Biomedical Research Center have learned a substantial proportion of individuals with extreme obesity can lose 10-percent or more of their body weight through medical treatment that does not include surgery.

27 Jan 2010

MAQUET Cardiovascular initiates study evaluating EVH in CABG compared to open vein harvesting

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting. David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.

27 Jan 2010

Study: PROSTVAC-VF vaccine effective in treating patients with metastatic prostate cancer

In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations.

27 Jan 2010

Asan Medical Center, Chemizon enter into multi-year research collaboration agreement

Asan Medical Center and Chemizon, the drug discovery division of Optomagic, Co. Ltd., announced today that they have entered into a multi-year research collaboration to discover and develop novel, small molecule oncology therapeutics.

27 Jan 2010

Clinical Trial News and Research

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

Orthopaedic researchers explore novel treatments for wounded soldiers

PHT announces enhanced StudyWorks portal for clinical trial management

New report illustrates why cardiovascular disease is under-recognized and under-treated in women

Special issue explores how evolution can help doctors understand and treat diseases

GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patients

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Seroquel XR's FDA approval does not change Decision Resources' earlier antipsychotics market forecast

Santica Research Labs launches CelluScience Anti-Cellulite Beaute Intensive dietary supplement

Scientists uncover a key cellular mechanism that alters brain cell function in Huntington's disease

PRA International enters into partnership agreement with Oncopartners and IBPC

Abbott declares quarterly dividend of 40 cents per share

Positive results from Supernus Pharmaceuticals' SPN 810 Phase IIa trial for ADHD

EU Clinical Trials Directive: ECCO supports proposals by its member organisations

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

Souvenaid slows worsening of memory difficulties in persons with mild to moderate Alzheimer's

Trial results show primary care doctors are capable of helping obese patients to lose weight

MAQUET Cardiovascular initiates study evaluating EVH in CABG compared to open vein harvesting

Study: PROSTVAC-VF vaccine effective in treating patients with metastatic prostate cancer

Asan Medical Center, Chemizon enter into multi-year research collaboration agreement

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News